Inve India ▾

Dabur India share price & results

Dabur India· Fast Moving Consumer Goods

Results to
Jun 2026
Latest analysed call
Q1 FY27
Ownership as of
Sept 2026

World's largest Ayurvedic and natural healthcare company, selling HPC, health and food brands globally.

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue2,687 ₹ crore+8.8% YoYQuarterly, as filedQuarter to Jun 2026Revenue from operations as filed.
Operating margin20.0 %0.0 pts YoYOperating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit452 ₹ crore+11.1% YoYQuarterly, as filedQuarter to Jun 2026Profit after tax as filed.
Return on equity17.87 %+0.0 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Adjusted profit attributable to owners ÷ average owners’ equity.
Free cash flow margin16.52 %+5.0 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)7.39 %+3.7 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Guidance

What management said, and what became of it

2 of 3 judged targets kept · 9 open · verdicts reflect calls analysed to Q1 FY27.

Dabur India management guidance track record on Inve: 12 targets tracked across analysed earnings calls (2 achieved, 1 missed, 9 open).

TargetOriginal wordingSaidLatest callVerdict
Strategic Review TimelinePlan to conclude the same by end of the fiscal year [FY25].
Call transcript, Q3 FY25 · 30 Jan 2025		Q3 FY25Q1 FY27:Historical achievement. No new updates.
Call transcript, Q1 FY27 · 29 Jul 2026		Achieved
Revenue GrowthWe are gunning towards double-digit growth in the 2nd Quarter.
Call transcript, Q1 FY26 · 31 Jul 2025		Q1 FY26Q1 FY27:Historical miss for Q2 FY26.
Call transcript, Q1 FY27 · 29 Jul 2026		Missed
Revenue GrowthWe are seeing high single to a low double-digit growth because you've got some pricing coming in because of inflation.
Call transcript, Q4 FY26 · 7 May 2026		Q4 FY26Q1 FY27:Guidance firmed up from 'high single to low double-digit' to a maintained 'double-digit growth' for the full year at the consolidated level. Q1 growth was 10.6%.
Call transcript, Q1 FY27 · 29 Jul 2026		Revised Up

Source: Inve Guidance Tracker for Dabur India · to Q1 FY27

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

1 of Dabur India's 12 targets was missed. See which ones, and which are quietly gone. The 3 above are the free sample; 9 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. Pro opens 100 a month, ₹499.
See the full record

Price

₹357.8 −0.42% · −₹1.5

Last close 27 Oct 2026 · NSE · INR · Source: Inve

Performance −29.6% 1Y

₹350₹400₹450₹500Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26Oct 26Q2 FY26 — 30 Oct 2025Q3 FY26 — 29 Jan 2026Q4 FY26 — 7 May 2026Q1 FY27 — 29 Jul 2026

1Y: ₹508.45 on 24 Oct 2025 → ₹357.8. High ₹525.35 (22 Jan 2026), low ₹357.8 (27 Oct 2026).

Previous close
₹359.3
Market cap
₹63.5k Cr
52-week range
₹357.8 – ₹525.35
One year
−29.43%
Price to earnings (TTM to Jun 2026)
32.00×
Return on equity (TTM to Jun 2026)
17.87%

Overview

Symbol
NSE:DABUR
Exchange
NSE
Currency
INR

What Dabur India does

Based on the company's own presentations, annual report and earnings calls.

Dabur India makes and sells branded consumer products across Home & Personal Care, Healthcare, and Food & Beverages, earning through wholesale/retail distribution of Ayurveda-based FMCG brands sold domestically and through an International Business spanning the Middle East, Africa, Europe, the US and other markets. Its portfolio spans hair care, oral care, home care and skin care, OTC/ethical health products, health supplements and digestives, and packaged foods and juices under the Real, Badshah and other labels. The company is also expanding its manufacturing footprint, including its first plant in South India (Tamil Nadu), and sources herbs through a network of contracted farmers for its Ayurvedic formulations.

Segments

  • Home & Personal Care (HPC)
  • Healthcare
  • Foods & Beverages (F&B)
  • International Business
Market position
One of the world's largest Ayurvedic and natural healthcare companies
Country reach
Products reach households in over 120 countries
Household penetration in India
8 out of every 10 Indian households use at least one Dabur product
Scaled brand portfolio
22 brands each generating over Rs.100 crore in annual revenue, including 3 brands over Rs.1,000 crore (Dabur Amla, Dabur Red Toothpaste, Real)
Operating heritage
Over 140 years of operating history
Manufacturing footprint expansion
First manufacturing facility in South India (Tamil Nadu) under development, to create 250 direct jobs
Headquarters New Delhi, India Company website

How the price took the results

close before → close after

Q1 FY27
+2.1%
29 Jul
Q4 FY26
+0.8%
7 May
Q3 FY26
−1.0%
29 Jan
Q2 FY26
−1.3%
30 Oct

The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.

Your own record

Start an Inve Case for Dabur India

Free account: one company. Everything above stays public.

Write why you follow Dabur India and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading

Other Fast Moving Consumer Goods companies

All Fast Moving Consumer Goods companies → · Fast Moving Consumer Goods earnings growth →

Learn to analyse Dabur India

Guides on how to read this kind of business and the numbers that matter.